Sun Pharma accused in US court of collusive price fixing - (Business Standard via NewsPoints Desk)

  • A lawsuit filed in Pennsylvania state court by a New York grocery workers' union accuses Sun Pharmaceutical of colluding with Mylan to hike the prices of the asthma drug albuterol, as reported Business Standard Monday.

  • The group previously accused Mylan and Novartis' Sandoz unit of colluding to raise the price of the asthma drug benazepril.

  • In the current litigation, the union contends that Sun Pharma and Mylan raised the prices of albuterol by more than 300 percent between October 2013 and April 2014.

  • "The increases were the result of an agreement among defendants to increase pricing and restrain competition for the sale of albuterol sulphate in the United States," the lawsuit states.

  • The news comes after Aurobindo Pharma, Heritage, Mylan, Teva, Citron Pharma and Mayne Pharma were accused by nearly 40 US states of conspiring in the markets for doxycycline and glyburide.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles